Difference between revisions of "Insulin"
m |
|||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Insulin.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 23: | Line 23: | ||
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | [[ | + | | [[TG2 reactive residues (Insulin)|chain A - Q5, Q15]] |
| − | [[ | + | [[TG2 reactive residues (Insulin)|chain B - Q4]] |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| Line 50: | Line 50: | ||
| * the Cys residues are oxidized | | * the Cys residues are oxidized | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:45, 10 March 2015
| Insulin | |
|---|---|
| |
| Substrate peptide name | Insulin |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P08865 |
| Reactive glutamines | chain A - Q5, Q15 |
| Reactive lysines | - |
| Substrate sequence | chain A - GIVEQC*C*ASVC*SLYQLENYC*N
chain B - FVNQHLC*GS |
| Structure | 1BEN |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:14342319 |
| Notes | * the Cys residues are oxidized |
